WallStreetZenWallStreetZen

NASDAQ: BCYC
Bicycle Therapeutics PLC Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BCYC past revenue growth

How has BCYC's revenue growth performed historically?
Company
86.52%
Industry
148.64%
Market
17.33%
BCYC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BCYC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BCYC's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BCYC earnings and revenue history

Current Revenue
$27.0M
Current Earnings
-$180.7M
Current Profit Margin
-669.7%

BCYC Return on Equity

Current Company
-57.8%
Current Industry
-63.5%
Current Market
188%
BCYC's Return on Equity (-57.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BCYC announces earnings.

BCYC Return on Assets

Current Company
-34.1%
Current Industry
2.9%
BCYC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BCYC Return on Capital Employed

Current Company
-33.46%
Current Industry
19.5%
BCYC has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BCYC vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BCYC$26.98M-$169.40M-$180.66M+30.47%N/A
INVA$310.46M$248.96M$179.72M+3.53%-6.84%
MDXG$321.48M$32.57M$58.23M-2.19%N/A
LQDA$17.49M-$69.65M-$78.50M+45.23%N/A
CNTA$6.85M-$165.43M-$151.09MN/AN/A
View Top Biotech Stocks

BCYC earnings dates

Next earnings date
May 2, 2024

Bicycle Therapeutics Earnings & Revenue FAQ

What were BCYC's earnings last quarter?

On Invalid Date, Bicycle Therapeutics (NASDAQ: BCYC) reported Q4 2023 earnings per share (EPS) of -$1.13, up 11.88% year over year. Total Bicycle Therapeutics earnings for the quarter were -$49.10 million. In the same quarter last year, Bicycle Therapeutics's earnings per share (EPS) was -$1.01.

If you're new to stock investing, here's how to buy Bicycle Therapeutics stock.

What was BCYC's earnings growth in the past year?

As of Q2 2024, Bicycle Therapeutics's earnings has grown year over year. Bicycle Therapeutics's earnings in the past year totalled -$180.66 million.

What is BCYC's earnings date?

Bicycle Therapeutics's earnings date is Invalid Date. Add BCYC to your watchlist to be reminded of BCYC's next earnings announcement.

What was BCYC's revenue last quarter?

On Invalid Date, Bicycle Therapeutics (NASDAQ: BCYC) reported Q4 2023 revenue of $5.33 million up 67.38% year over year. In the same quarter last year, Bicycle Therapeutics's revenue was $3.19 million.

What was BCYC's revenue growth in the past year?

As of Q2 2024, Bicycle Therapeutics's revenue has grown 86.52% year over year. This is 62.12 percentage points lower than the US Biotechnology industry revenue growth rate of 148.64%. Bicycle Therapeutics's revenue in the past year totalled $26.98 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.